Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/06/069272
CTRI/2024/06/069272
Not yet recruiting
Phase 2

A randomized study for assessing the efficacy of individualized homoeopathic medicines prescribed in 50 millesimal potency and centesimal potency in treatment of patient with pre-menstrual syndrome (PMS) among age group 18 to 25 years - NI

Dr Alpesh Jayswal0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Alpesh Jayswal
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr Alpesh Jayswal

Eligibility Criteria

Inclusion Criteria

  • •1 Cases suffering from PMS.
  • •2 Age between 18 to 25 years
  • •3 PMS Diagnosed cases with Pre\-Menstrual syndrome Scale (PMSS) Score is 80 or above 80\.
  • •4 Willingness to Participate Participants who provide informed consent and are willing to comply with the study requirements, including attending scheduled visits and following the prescribed treatment regimen.

Exclusion Criteria

  • •1 Married Women
  • •2 Participants with Menstrual irregularities like Leucorrhoea, Dysmenorrhoea, Menorrhoea ,Metrorrhagea, PCOS
  • •3 Medical Conditions Participants with severe medical conditions or comorbidities that may interfere with the assessment of PMS symptoms or pose a risk to their well\-being.
  • •4 Psychiatric Disorders Participants with severe psychiatric disorders, such as major depressive disorder or bipolar disorder, which may require alternative treatment approaches.
  • •5 Hormonal Treatment Participants currently receiving or planning to initiate hormonal treatments specifically for PMS during the study period, as this may confound the evaluation of homoeopathic treatment efficacy.
  • •6 Previous Homoeopathic Treatment Participants who have received homoeopathic treatment for PMS within a defined period (e.g 3 months) prior to the study initiation.
  • •7 Allergy or Sensitivity Participants with known allergies or sensitivities to homoeopathic medicines or their components.
  • •8 Substance abuse and/or dependence
  • •9 Diagnosed or suspected cases of any malignancy
  • •10 Patients taking Allopathic or any other systemic medicine

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 3
A Study to find out the effectiveness of Gabapentin on patients who develop pain due to oral mucositis while they are on chemo-radaition therapy with Head and Neck Cancers with the site of tumor at the following regions (oral & oropharynx versus larynx & hypopharynx).Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx
CTRI/2020/03/024269Tata Memorial Hospital
Active, not recruiting
Phase 1
A study to evaluate the efficacy of ingenol mebutate on precancerosis and its contigous area compared to cryotherapyactinic keratoses and field cancerizationMedDRA version: 20.0Level: PTClassification code 10000614Term: Actinic keratosisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
EUCTR2015-005820-24-ITA.O.U. Università degli Studi della Campania Luigi Vanvitelli50
Not yet recruiting
Phase 2
Tenecteplase versus Alteplase before Endovascular Therapy for Ischemic Stroke (EXTEND-IA TNK)
ACTRN12615000220561euroscience Trials Australia64
Not yet recruiting
Phase 2
Effectiveness of Salbutamol in treatment of TTNB- A RCT STUDY
CTRI/2023/09/057567Department of pediatrics INHS ASVINI
Completed
Not Applicable
Evaluation of the effectiveness of Neuro Psycho Physical Optimization with Conveyer of Modulating Radiance (CMR) in stress-related physical and mental effort.
ACTRN12607000497404Istituto Rinaldi Fontani720